Leeds Teaching Hospitals NHS Trust

Leeds, England LS97TF

1 studies enrolling now · 3 studies all time

What they study most

Duchenne Muscular Dystrophy, Focal Epilepsy, Indolent Non-Hodgkin's Lymphomas, Tonic-Clonic Seizures

Studies at this site

• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD — Stopped early
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early